BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29343185)

  • 1. Exploring protein-protein intermolecular recognition between meprin-α and endogenous protease regulator cystatinC coupled with pharmacophore elucidation.
    Chaudhuri A; Biswas S; Chakraborty S
    J Biomol Struct Dyn; 2019 Feb; 37(2):440-453. PubMed ID: 29343185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore modeling coupled with molecular dynamic simulation approach to identify new leads for meprin-β metalloprotease.
    Chaudhuri A; Hudait N; Chakraborty SS
    Comput Biol Chem; 2019 Jun; 80():292-306. PubMed ID: 31054542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights from Analysis of Binding Sites of Human Meprins: Screening of Inhibitors by Molecular Dynamics Simulation Study.
    Chaudhuri A; Bera AK; Sarkar I; Chakraborty S
    Comb Chem High Throughput Screen; 2016; 19(3):246-58. PubMed ID: 26875789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated
    Dholey Y; Chaudhuri A; Sen Chakraborty S
    J Biomol Struct Dyn; 2020 Apr; 38(7):2080-2092. PubMed ID: 31184526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation mechanism of meprins, members of the astacin metalloendopeptidase family.
    Johnson GD; Bond JS
    J Biol Chem; 1997 Oct; 272(44):28126-32. PubMed ID: 9346968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetuin-A and cystatin C are endogenous inhibitors of human meprin metalloproteases.
    Hedrich J; Lottaz D; Meyer K; Yiallouros I; Jahnen-Dechent W; Stöcker W; Becker-Pauly C
    Biochemistry; 2010 Oct; 49(39):8599-607. PubMed ID: 20806899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two alpha subunits and one beta subunit of meprin zinc-endopeptidases are differentially expressed in the zebrafish Danio rerio.
    Schütte A; Lottaz D; Sterchi EE; Stöcker W; Becker-Pauly C
    Biol Chem; 2007 May; 388(5):523-31. PubMed ID: 17516848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked differences between metalloproteases meprin A and B in substrate and peptide bond specificity.
    Bertenshaw GP; Turk BE; Hubbard SJ; Matters GL; Bylander JE; Crisman JM; Cantley LC; Bond JS
    J Biol Chem; 2001 Apr; 276(16):13248-55. PubMed ID: 11278902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary-Amine-Based Inhibitors of the Astacin Protease Meprin α.
    Tan K; Jäger C; Schlenzig D; Schilling S; Buchholz M; Ramsbeck D
    ChemMedChem; 2018 Aug; 13(16):1619-1624. PubMed ID: 29927060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
    Iqbal S; Anantha Krishnan D; Gunasekaran K
    J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta.
    Hirano M; Ma BY; Kawasaki N; Okimura K; Baba M; Nakagawa T; Miwa K; Kawasaki N; Oka S; Kawasaki T
    J Immunol; 2005 Sep; 175(5):3177-85. PubMed ID: 16116208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and Dynamics of Meprin β in Complex with a Hydroxamate-Based Inhibitor.
    Linnert M; Fritz C; Jäger C; Schlenzig D; Ramsbeck D; Kleinschmidt M; Wermann M; Demuth HU; Parthier C; Schilling S
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of dual-target natural inhibitors of meprins α and β metalloproteases for inflammation regulation: pharmacophore modelling, molecular docking, ADME prediction, and molecular dynamics studies.
    Eltaib L; Alzain AA
    SAR QSAR Environ Res; 2023 Nov; ():1-23. PubMed ID: 37955603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of binding sites of human meprins with hydroxamic acid derivative by molecular dynamics simulation study.
    Chaudhuri A; Sarkar I; Chakraborty S
    J Biomol Struct Dyn; 2014 Dec; 32(12):1969-78. PubMed ID: 24279637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing the protease web in skin: meprin metalloproteases are activated specifically by KLK4, 5 and 8 vice versa leading to processing of proKLK7 thereby triggering its activation.
    Ohler A; Debela M; Wagner S; Magdolen V; Becker-Pauly C
    Biol Chem; 2010 Apr; 391(4):455-60. PubMed ID: 20128684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the three-dimensional structure of astacin for the structure and function of the astacin family of zinc-endopeptidases.
    Stöcker W; Gomis-Rüth FX; Bode W; Zwilling R
    Eur J Biochem; 1993 May; 214(1):215-31. PubMed ID: 8508794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors.
    Fu Y; Sun YN; Yi KH; Li MQ; Cao HF; Li JZ; Ye F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28598377
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
    Tripathy S; Azam MA; Jupudi S; Sahu SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.